{"id":23489,"date":"2023-01-20T08:00:00","date_gmt":"2023-01-20T06:00:00","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/press-releases\/ipsen-presents-phase-iii-napoli-3-trial-of-onivyde-regimen-demonstrating-positive-survival-results-in-previously-untreated-metastatic-pancreatic-ductal-adenocarcinoma-at-asco-gi\/"},"modified":"2024-07-22T11:42:33","modified_gmt":"2024-07-22T09:42:33","slug":"ipsen-presents-phase-iii-napoli-3-trial-of-onivyde-regimen-demonstrating-positive-survival-results-in-previously-untreated-metastatic-pancreatic-ductal-adenocarcinoma-at-asco-gi","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-presents-phase-iii-napoli-3-trial-of-onivyde-regimen-demonstrating-positive-survival-results-in-previously-untreated-metastatic-pancreatic-ductal-adenocarcinoma-at-asco-gi\/","title":{"rendered":"Ipsen presents Phase III NAPOLI 3 trial of Onivyde\u00ae regimen demonstrating positive survival results in previously untreated metastatic pancreatic ductal adenocarcinoma at ASCO GI"},"content":{"rendered":"\n